Nykredit A/S’s HCA Healthcare HCA Stock Holding History

Nykredit A/S’s Portfolio HCA Stock Details HCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$16.2M	Buy	+41,672	New	+$17.6M	0.05%	269

Other funds holding HCA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Nykredit A/S's HCA Position: Q2 2026 in Review

Nykredit A/S opened a new position in HCA Healthcare (HCA) in Q2 2026: 41,672 shares worth $16.2M. The stake represents 0.05% of the portfolio and ranks #269 among its holdings.

1,094 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

Nykredit A/S held 41,672 shares of HCA Healthcare worth $16.2M as of Q2 2026.
HCA Healthcare was a new Nykredit A/S position in Q2 2026.
HCA Healthcare made up 0.05% of Nykredit A/S's portfolio in Q2 2026, its #269 holding.
1,094 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on Nykredit A/S's 13F filing for Q2 2026, filed 13 Aug 2026.